Infectious Disease

Explore Related Topics

Active Projects: 92

Project Investigator All Topics Start date End date
A Collaborative Approach to the Design of a Genetically-Stable Oral Polio Vaccine (OPV-2) Raul Andino-Pavlovsky, PhD Infectious Disease, Drug and Diagnostics Development
RAPID: Understanding and leveraging asymptomatic infections to control Ebola transmission Travis C. Porco, PhD, MPH Infectious Disease, Epidemiology and Surveillance
The Impact of WASH on Re-infection with STH Jeremy D. Keenan, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Epidemiology and Surveillance, Risk Reduction and Prevention
Impact of everolimus on HIV persistence post kidney (and kidney/pancreas) or liver transplant Peter G. Stock, MD, PhD Infectious Disease, Surgery and Anesthesia
Impact of everolimus on HIV persistence post kidney or liver transplant Peter G. Stock, MD, PhD Infectious Disease, Surgery and Anesthesia
Signaling by Cytoplasmic Tyrosine Kinases in Leukocytes Clifford A. Lowell, MD, PhD Infectious Disease, Noncommunicable and/or Chronic Disease, Risk Reduction and Prevention
Fetal HCMV Infection: Role of the Human Placenta Lenore Pereira, PhD Infectious Disease, Women's Health, Newborn and Infant Health
The PIP2-Virus Interface and PI 4-Kinase: Novel Biology and Validation Targets Kevan Shokat, PhD Zoonosis, Emerging Disease, and Drug Resistance
Sexually Transmitted Infections Clinical Trials Group (STICTG) Linda C. Giudice, MD, PhD, MSc Sexually Transmitted Infections (STIs)
Cryptococcus neoformans Knockout Resource Hiten D. Madhani, MD, PhD Infectious Disease
Digital Disease Detection and Molecular Epidemiology of Viral Pathogens in Peru Simon D. Pollett, MBBS Infectious Disease, Epidemiology and Surveillance
STI Screening as a Combined HIV Prevention Platform for MSM in Peru James W. Dilley, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science, Engagement in Care
Study for Sample Acquisition for Patients Diagnosed with S. aureus Bacteremia Henry Chambers, MD Infectious Disease, Drug and Diagnostics Development, Epidemiology and Surveillance
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Policy, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, International Health Policy, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus, Continuation A120553 Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
HIV Transmission Cluster Analysis to Inform Prevention Hong-Ha M. Truong, PhD, MS, MPH Infectious Disease, HIV/AIDS, Neurology and Mental Health, Risk Reduction and Prevention
Newborn Screening for T-Cell Disorders: Spectrum and Outcomes Jennifer M. Puck, MD Infectious Disease, Newborn and Infant Health, Risk Reduction and Prevention
Natural History of HPV in Teens-Infection to Neoplasia Stephen Shiboski, PhD Sexually Transmitted Infections (STIs), Cancer/Oncology, Adolescent Health
Identifying and Modulating Therapeutic Targets in a Model of Hepatitis B Jody L. Baron, MD, PhD Infectious Disease
YV25718: A phase IIIb parallel group, open label study of pegylated interferon alfa-2a monotherapy (PEG-IFN, Ro 25-8310) compared to untreated control in children with HBeAg positive chronic hepatitis B Philip Rosenthal, MD Infectious Disease, Pediatrics
Identification of Signaling Pathways Associated with Lyme Disease Charles Y. Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG Infectious Disease, HIV/AIDS, Drug and Diagnostics Development, Women's Health, Training International Scholars and Clinicians, Patient and Peer Education
Biology of Infectious Diseases Training Program Henry Chambers, MD Infectious Disease, Residencies, Fellowships, and Postdoctoral Training
Novel approaches to identify host genes required for Chlamydia pathogenesis Joanne N. Engel, MD, PhD Infectious Disease, Sexually Transmitted Infections (STIs), Drug and Diagnostics Development
HARC Center: HIV Accessory and Regulatory Complexes Alan D. Frankel, PhD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Immunology
BRASL - A rapid Barcoded RNA Annealing, Selection, and Ligation assay to detect pathogens. Eric D. Chow, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
NTD (Neglected Tropical Diseases) Modelling Consortium Thomas M. Lietman, MD Neglected Tropical Diseases (NTDs), Epidemiology and Surveillance
Merck Men's Efficacy Study, V501 Joel Palefsky, MD Infectious Disease
A Two-Part, Open-Label, Single-Arm Phase 1/2 Study of Safety, Pharmacokinetics, and Efficacy of Telaprevir in Combination with Peginterferon alfa-2b and Ribavirin in Pediatric Subjects Aged 3 to 17 Infected With Genotype 1 Hepatitis C Virus Philip Rosenthal, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment, Pediatrics
A Randomized, Double Blinded, Active-Controlled Study of Cb-183,315 in Patients with Clostridium-difficile-Associated Diarrhea Sarah B. Doernberg, MD Infectious Disease, Drug and Diagnostics Development
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne F. Luetkemeyer, MD Sexually Transmitted Infections (STIs)
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne F. Luetkemeyer, MD Sexually Transmitted Infections (STIs)
Chemical Methods for Ferrous Iron Dependent Drug Delivery Adam R. Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B Mandana Khalili, MD Infectious Disease
AI452-020-0092: Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic Hepatitis C who are Treatment-naïve or Re Mandana Khalili, MD Sexually Transmitted Infections (STIs)
GSK Zoster2-Observer blind study to evaluate efficacy, safety, and immunogenictiy of GSK Biologicals Herpes Zoster vaccine Charalambos (Babis) Andreadis, MD Infectious Disease
Disrupting Vector-Borne Disease Transmission in Complex Urban Environments Caryn L. Bern, MD, MPH Neglected Tropical Diseases (NTDs), Epidemiology and Surveillance
The Microbiome, Virome and Host Response in Ventilator Associated Pneumonia Joseph L. Derisi, PhD Infectious Disease, Opportunistic Infection
Prevalence of baseline and longitudinal heteroresistant M. tuberculosis and association with patient-important outcomes John J. Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir®, in Orthotopic Liver Transplant Recipients Norah A. Terrault, MD Infectious Disease, Pharmacology and Drug Treatment
California Department of Public Health (CDPH) Immunization Branch Contract George W. Rutherford, MD Infectious Disease, Engagement in Care, Risk Reduction and Prevention
HIV, HCV, and gender effects on Liver, Bone, and Vascular Health Phyllis C. Tien, MD Infectious Disease, HIV/AIDS
Novel methods for monitoring long-term drug exposure and resistance amplification during treatment of multidrug resistant tuberculosis John J. Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Patients with Chronic Hepatitis B Infection Philip Rosenthal, MD Infectious Disease
Predicting Progression of Human Prion Disease Michael D. Geschwind, MD, PhD Infectious Disease, Neurology and Mental Health
Phase 2, Open-Label, Multicenter, Multi-cohort, Single-Arm Study to Investigate the Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children with Genotype 2 or 3 Chronic HCV Infection Philip Rosenthal, MD Infectious Disease, Pharmacology and Drug Treatment
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis Mandana Khalili, MD Sexually Transmitted Infections (STIs)
HBV/HIV Co-Infection Research Network Mandana Khalili, MD Sexually Transmitted Infections (STIs), HIV/AIDS
A cognitive behavioral and structural HIV prevention intervention for young Ugandan women engaging in high risk sexual behavior Rachel King, PhD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Implementation and Behavioral Science, Risk Reduction and Prevention
Village Integrated Eye Workers Trial Thomas M. Lietman, MD Infectious Disease, Eye Disease and Blindness, Risk Reduction and Prevention
Hepatitis C Therapeutic Registry and Research Network (HCV-TARGET) Kathleen P. Tebb, PhD Infectious Disease, Cancer/Oncology
Natural History of HPV in Teens-Infection to Neoplasia Stephen Shiboski, PhD Sexually Transmitted Infections (STIs), Cancer/Oncology, Adolescent Health
Pedig-Master Agreement - Jaeb Center for Health Research, Inc. Alejandra G. De Alba Campomanes, MD, MPH Infectious Disease, Eye Disease and Blindness, Pediatrics
Thai Red Cross S&S, HPV TA008 Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Pharmacology and Drug Treatment
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
Strategic Information Technical Assistance Consortium George W. Rutherford, MD Infectious Disease, Epidemiology and Surveillance
De Facto Monotherapy during Multidrug Tuberculosis Treatment and Emergence of Resistance Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic Kevan Shokat, PhD Zoonosis, Emerging Disease, and Drug Resistance
Integrated Training in Reproductive Sciences Synthia Mellon, PhD Sexually Transmitted Infections (STIs), Genetics, Family Planning, Residencies, Fellowships, and Postdoctoral Training
Host-Directed Strategies to Create Synergistic Antibacterial Therapies Jeffery S. Cox, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development, Immunology
Interaction between Innate and Th2 Lymphocytes in Helminth Immunity Jesse C. Nussbaum, MD Zoonosis, Emerging Disease, and Drug Resistance
Novel Microbiota-Derived Molecules That Modulate the Host Immune Response Michael Fischbach, PhD Zoonosis, Emerging Disease, and Drug Resistance
Trefoil Factor Proteins Modulate Host Immunity against Hookworms De'Broski Herbert, PhD Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Pegylated Interferon Lambda w/wo Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 Mandana Khalili, MD Sexually Transmitted Infections (STIs)
Translational Approaches to Develop Drug Therapy for Diarrhea Alan S. Verkman, MD, PhD Infectious Disease, Pediatrics
Understanding the Interpersonal Context of HIV/HCV risk within Injecting Dyads Meghan Morris, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology
International Traineeships in AIDS Prevention Studies (ITAPS) George W. Rutherford, MD Infectious Disease, HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Sanitation, Water, and Instruction in Face-washing for Trachoma (SWIFT) Jeremy D. Keenan, MD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Structural and Functional Studies of HER Receptor Tyrosine Kinases Natalia Z. Jura, PhD Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Acute Hepatitis C Infection in Young Injectors (incoming sub) Judith A. Hahn, PhD, MD Infectious Disease, Substance Abuse
Resistance of Malaria Parasites to Artemisinin-Based Therapies Philip J. Rosenthal, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
New approaches to study Pseudomonas-host interactions Joanne N. Engel, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting Norah A. Terrault, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Gene circuits that control morphology in Histoplasma Anita Sil, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies Norah A. Terrault, MD Infectious Disease
Immunology & epidemiology of intestinal infectious diseases Robert Owen, MD Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Epidemiology and Surveillance
Travel Medicine in Global Health Mary E. Wilson, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Burkitt’s lymphoma and Kaposi’s sarcoma in Uganda John Ziegler, MD, MSc Infectious Disease, HIV/AIDS
Evidenced-based guidelines specific to resource challenged settings Teresa Bleakly Kortz, MS, MD Infectious Disease, Health Systems Strengthening
Epigenetic control of virulence in a fungal meningitis pathogen Hiten D. Madhani, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
AIDS Education and Training Center, National Clinician Consultation Center Ronald H. Goldschmidt, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
Naturally acquired immunity to norovirus in a newborn cohort in Peru Caryn L. Bern, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Newborn and Infant Health
International Training in Transfusion Medicine Mike Busch, MD, PhD Infectious Disease, Epidemiology and Surveillance, Health Systems Strengthening, Training International Scholars and Clinicians
Blood safety standards and lab capacity in low & mid income countries Elizabeth Donegan, MD Infectious Disease, HIV/AIDS, Training International Scholars and Clinicians
Transfusion medicine and Blood safety: Policy, Diagnostics and Standards development Mike Busch, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), International Health Policy, Systematic Reviews and Guideline Development, Health Systems Strengthening
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection John J. Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) Peter W. Hunt, MD Infectious Disease, HIV/AIDS, Tuberculosis
Mortality Reduction After Oral Azithromycin Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Epidemiology and Surveillance
Updating HCV treatment engagement paradigms for HIV/HCV coinfected patients Elise Riley, PhD Infectious Disease, HIV/AIDS, Engagement in Care
Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) Marion G. Peters, MD Infectious Disease, HIV/AIDS
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Infectious Disease, HIV/AIDS, Pediatrics, Newborn and Infant Health, Risk Reduction and Prevention
STD Prevention Training Center George W. Rutherford, MD Sexually Transmitted Infections (STIs), Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education

Active Projects: 273

Project Investigator All Topics Start date End date
HIV Clinical Scholars Fellowship Royce C. Lin, MD Infectious Disease, HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
HIV Clinical Scholars Fellowship Royce C. Lin, MD Infectious Disease, HIV/AIDS, Training International Scholars and Clinicians
Chlamydia and Gonococcal Infection: Immunobiology in the Female Reproductive Tract Craig Cohen, MD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health
Acceptability of Barrier Methods for Disease Prevention Nancy S. Padian, PhD Sexually Transmitted Infections (STIs)
San Francisco STDs CRC Nancy S. Padian, PhD Sexually Transmitted Infections (STIs), Adolescent Health
Retrovirus Epidemiology Donor Study (REDS) Edward L. Murphy, MD, MPH Infectious Disease, Health Systems Strengthening, Risk Reduction and Prevention
Acceptability of Diaphragm Use to Prevent STDs/HIV Nancy S. Padian, PhD Sexually Transmitted Infections (STIs), Women's Health
Intervention to Decrease Risk for STDs and Unintended Pregnancies in Active Duty Military Women Cherrie B. Boyer, PhD Sexually Transmitted Infections (STIs), Women's Health, Family Planning
Proposed Experiments to Study Emergence of Antimicrobial Resistance in Methicillin- Resistant Strains of Staphylococcus aureus Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
Mycoplasma Genitalium in the Female Genital Tract Craig Cohen, MD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health
Cap Independent Translation of Dengue Virus Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Women and Infants Transmission Study - Human Papillomavirus Protocol Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology, Women's Health
State Sexually Transmitted Disease Collaborative Program George W. Rutherford, MD Sexually Transmitted Infections (STIs), Epidemiology and Surveillance, Risk Reduction and Prevention
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults with Compensated Chronic Hepatitis B Mandana Khalili, MD Infectious Disease
Improving Uses of New and Existing Technologies to Reduce Non-viral STIs in Developing Countries Nancy S. Padian, PhD Sexually Transmitted Infections (STIs)
HIV Risk Reduction Through HSV-2 Prevention with N-9 Nancy S. Padian, PhD Sexually Transmitted Infections (STIs)
Sexually Transmitted Disease Prevention Projects: Implementation George W. Rutherford, MD Sexually Transmitted Infections (STIs), Epidemiology and Surveillance, Risk Reduction and Prevention
Drug Resistant Malaria Clinical and Laboratory Studies Zoonosis, Emerging Disease, and Drug Resistance, Malaria
HCV Infection and Treatment in Parolees: Feasibility Study Kimberly A. Page, PhD, MPH Sexually Transmitted Infections (STIs)
High Throughput Assay for Screening Compounds Against T. Brucei Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Development and Testing of New Medications for the Treatment of Emerging Infectious Diseases [I] Philip J. Rosenthal, MD Infectious Disease, Drug and Diagnostics Development
Optimization of Cysteine Protease Inhibitors Targeting Trypanosoma Brucei Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
A Prophylactic Strategy Using Voriconazole vs. Inhaled Amphotericin to Prevent Invasive Aspergillosis in Lung Transplant Recipients Peter Chin-Hong, MD Infectious Disease, Opportunistic Infection, Chronic Respiratory Disease
Investigation of the Natural History of Human Papillomavirus (HPV) DNA and Cervical Neoplasia in a Cohort of Sex Workers in Kenya Craig Cohen, MD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health
Enfuvirtide Intensification for Multi-Drug Resistant HIV Steven G. Deeks, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
Hemin Receptor Gene Family of Bartonella quintana Jane Koehler, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
STD Risks and Latino Adolescents' Sexual Networks Nancy S. Padian, PhD Sexually Transmitted Infections (STIs), Adolescent Health
Randomized Controlled Trial of 6% Cellulose Sulfate Gel and the Effect on Vaginal HIV Transmission Ariane Van der Straten, PhD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Pharmacology and Drug Treatment
Insulin Resistance in HCV Infection Mandana Khalili, MD Sexually Transmitted Infections (STIs)
Applied Research on Antimicrobioal Resistance: Molecular Epidemiology of Community Methicillin-resistant Staphylococcus aureus (MRSA) Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
Protocol Development for a Phase 2 Study Evaluating the Safety and Feasibility of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
HSV-2 Avidity Testing for Intervention for Male Sexually-Transmitted Disease (STD) Patients in India Christina (Krysia) P. Lindan, MD, MSc Sexually Transmitted Infections (STIs), HIV/AIDS
Schistosoma mansoni: Identification and Validation of New Targets for Therapy Using a siRNA Screen Conor R. Caffrey, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Strategies for the Control and Elimination of Blinding Trachoma Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
PEGASYS plus Copegus in treatment-naïve Latino patients with chronic hepatitis C-genotype 1, as compared to treatment-naïve non-Latino White patients with chronic hepatitis C-genotype 1 Mandana Khalili, MD Infectious Disease
The Connie Wofsy Womens' HIV Study Ruth M. Greenblatt, MD Infectious Disease, HIV/AIDS, Women's Health
A Phase I Safety Trial of the Diaphragm in Zimbabwe Nancy S. Padian, PhD Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Family Planning
What is the Appropriate Frequency and Duration of Mass Azithromycin Thomas M. Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
An Intervention for Male STD Patients in India / HIV Related Christina (Krysia) P. Lindan, MD, MSc Sexually Transmitted Infections (STIs), HIV/AIDS
Anal Human Papillomavirus (HPV) in Methamphetamine (MA) Using and Non-Using Men Who Have Sex with Men (MSM) in Los Angeles Joel Palefsky, MD Infectious Disease, Cancer/Oncology, Substance Abuse, Risk Reduction and Prevention
Providers' Perceptions of the Diaphragm in Southern Africa and the United States Cynthia C. Harper, PhD Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Training International Scholars and Clinicians, UCSF Professional Education
Novel Anti-Malarials by Combinatorial Pharmacogenomics Joseph L. Derisi, PhD Infectious Disease, Malaria, Drug and Diagnostics Development
Natural History of Acute and Chronic HCV in Blood Donors Edward L. Murphy, MD, MPH Infectious Disease
Specialized Infectious Disease Control Program George W. Rutherford, MD Infectious Disease
Host Protein Degradation by Schistosome Parasites Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Phase 2 Study, Safety of and Rate of Bacterial Clearance of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
A Phase 2, Randomized, Open-Labeled Study on the Safety of and Rate of Bacterial Clearance of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
Human Papillomavirus as a Risk Factor for HIV Infection Peter Chin-Hong, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS
Hepatocellular Carcinoma Screening Practices in Hepatitis B (HBV) Infected Asian Americans Mandana Khalili, MD Infectious Disease
Regulation of the Development of Tryanosoma brucei Ching C. Wang, MD Infectious Disease
Acute Hepatitis C Infection in Young Injectors Kimberly A. Page, PhD, MPH Sexually Transmitted Infections (STIs)
Specialized Infectious Disease Control Program George W. Rutherford, MD Infectious Disease
Economic Opportunity for Zimbabwean Adolescent Orphans Philip D. Darney, MD, MS Sexually Transmitted Infections (STIs), HIV/AIDS
Hcv-Induced Alterations in Glucose Metabolism Mandana Khalili, MD Infectious Disease, Diabetes
Bartonella Virulence Mechanisms in Patients with AIDS Jane Koehler, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS
Multidrug-Resistant CA-MRSA Infections Among HIV+ Persons: CA AIDS Grant ID07-REI-129 Henry Chambers, MD Infectious Disease, Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Epidemiology and Surveillance
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus Mandana Khalili, MD Infectious Disease, Pharmacology and Drug Treatment
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus Mandana Khalili, MD Infectious Disease
PCP OPW Specimens/Uganda Project Support Laurence Huang, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
State Sexually Transmitted Disease Collaborative Program George W. Rutherford, MD Sexually Transmitted Infections (STIs)
Regulation of the Development of Trypanosoma brucei Ching C. Wang, MD Infectious Disease
UCDRD Whitepaper: Viral Pathogens Joseph L. Derisi, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Subcontract Work in Association with LLNL LDRD Project: COMP-08ERD036 Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Support for Male Circumcision Evalutation Meeting George W. Rutherford, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Risk Reduction and Prevention
Transcriptional Responses of Parasite and Host during Intestinal Colonization and Invasion by Entamoeba histolytica Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Sangre Segura: An Epidemiological Study of Blood Transfusion Safety in the Mexico-U.S. Border Region Edward L. Murphy, MD, MPH Infectious Disease, Health Systems Strengthening, Risk Reduction and Prevention
Valley Fever Vaccine Project George W. Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
Tetrezolid vs. Daptomycin and Vancomycin for Treatment of Experimental Staphylococcus aureus Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
The Medical Consequences of Different Types of Heroin Daniel H. Ciccarone, MD, MPH Infectious Disease, HIV/AIDS, Substance Abuse
Targeting Cysteine Proteases--Antiparasitic Chemotherapy Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Microbicide Pregnancy Registry--Microbicide Trials Network Juan E. Vargas, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning
Central Nervous System Events in Primary HIV Infection Infectious Disease, HIV/AIDS, Neurology and Mental Health
Purine Metabolism in Trichomonas Vaginalis Ching C. Wang, MD Infectious Disease, Sexually Transmitted Infections (STIs)
Ceftobiprole vs. Daptomycin and Linezolid for Treatment of Experimental Staph. aureus Endocarditis in Rabbits Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
HIV, Hepatitis C, and Pruritus: Data from the Women's Interagency HIV Study Toby A. Maurer, MD Infectious Disease, HIV/AIDS, Women's Health
Congenital Syphilis Elimination Cost-Effectiveness Analysis James G. Kahn, MD, MPH Sexually Transmitted Infections (STIs), Health Economics and Policy
Hepatitis C: Studies of Immunity and Pathogenesis Kimberly A. Page, PhD, MPH Sexually Transmitted Infections (STIs)
Satellite Symposium at Microbicides 2010 on Bacterial Therapeutics Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane V. Havlir, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
HIV-HEP C Website Maintenance Services Susan C. Coffey, MD Infectious Disease, HIV/AIDS, Patient and Peer Education
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia Anne F. Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Content from UCSF Physicians for SexReally.com J. Joseph Speidel, MD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Family Planning, Adolescent Health, Patient and Peer Education
Core B: Intracellular Pathogens and Innate Immunity Joseph L. Derisi, PhD Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Prevention of Emergence of Antibiotic Resistant P. aeruginosa Susan Lynch, PhD Zoonosis, Emerging Disease, and Drug Resistance
Retrovirus Epidemiology Donor Study-II (REDS-II) Central Laboratory Mark Seielstad, PhD Infectious Disease, Sexually Transmitted Infections (STIs), Health Systems Strengthening
Genomic and Clinical Correlates of Human Bartonella Quintana Infection Jane Koehler, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Valley Fever Vaccine Project 2010 George W. Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
The Impact of Anogenital Human Papillomavirus in the Transmission of HIV in Urban Brazil: Phase II Study Joel Palefsky, MD Infectious Disease, Pharmacology and Drug Treatment
The Steroids for Corneal Ulcers Trial Thomas M. Lietman, MD Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment
Identification of Anti-HIV Lead Compounds Targeting Adam R. Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS
Retrovirus Epidemiology Donor Study-II REDS-II International Component - Blood Center Edward L. Murphy, MD, MPH Infectious Disease, Health Systems Strengthening
Development and Testing of New Medications for the Treatment of Emerging Infectious Diseases [II] Philip J. Rosenthal, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Malaria
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis Adam R. Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis Adam R. Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Elimination of Infectious Trachoma from Ethiopia Using Repeated Mass Antibiotic Distributions Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
Virus population dynamics, genetic diversity and evolution Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Programmable Genetic Memory in Bacteroides: Diagnosis of Diarrheal Disease Michael Fischbach, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Pediatrics, Newborn and Infant Health
Diagnosis, Prevention, and Management of Cryptococcus Infection (Meningeal and Non-Meningeal) George W. Rutherford, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
HIV Emergence of Drug Resistance Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
Trypanosome Drug Development Consortium Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Iron-Dependent Drug Delivery as a New Paradigm in Anti-Parasitic Chemotherapy and Prophylaxis Adam R. Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Leveraging Core Groups -- A New Way to Protect Against Infectious Trachoma Thomas M. Lietman, MD Infectious Disease, Eye Disease and Blindness, Epidemiology and Surveillance
Microbicide Pregnancy Registry-Microbicide Trials Network Juan E. Vargas, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health
XV International Conference on Human Retrovirology: HTLV and Related Viruses Edward L. Murphy, MD, MPH Infectious Disease, HIV/AIDS
Dynamic Modeling of the Hepatitis C Epidemic in Injection Drug Users Judith A. Hahn, PhD, MD Sexually Transmitted Infections (STIs), Epidemiology and Surveillance
Secretion of Virulence Factors by Mycobacterium tuberculosis Jeffery S. Cox, PhD Infectious Disease, HIV/AIDS, Tuberculosis, Genetics
Natural History and Outcomes of Coccidioidomycosis Retrospective Record Review Study Peter Chin-Hong, MD Infectious Disease, Opportunistic Infection, Systematic Reviews and Guideline Development
Efficacy Evaluation and Safety of Single-dose IV Oritavancin vs. IV Vancomycin for the Treatment of Patients with Acute Bacterial Skin and Skin Structure Infection (SOLO I) Henry Chambers, MD Infectious Disease
Expanded Access to MGAWN1 in Subjects with Suspected West Nile Neuroinvasive Disease; Substantial Exposure, or Infection and a Compromised Immune System Jeffrey W. Ralph, MD Zoonosis, Emerging Disease, and Drug Resistance, Pharmacology and Drug Treatment
Regulatory Networks That Control Cell Morphology and Virulence in the Fungal Respiratory Pathogen Histoplasma capsulatum Sinem Beyhan-Pelvan, PhD Infectious Disease
To Discover and Characterize Novel Viruses in Cancer Charles Y. Chiu, MD, PhD Infectious Disease, Cancer/Oncology
Vitamin A Metabolism and Helminth Infection J. Michael McCune, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Trial of T.cruzi DNA Vaccine in Experimental Model of Disease Challenge Infection Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Viral & Rickettsial Disease Laboratory (VRDL) Project George W. Rutherford, MD Infectious Disease
Viral Discovery in Human and Animal Samples Charles Y. Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Efficacy and Safety of Eraxis/Ecalta (Anidulafungin) Compared to Cancidas (Caspofungin) in Patients with Candida Deep Tissue Infection: A Phase 4 Study Peter Chin-Hong, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Evaluation of Abbott RealTime CT/NG for the Detection of C. trachomatis & N. gonorrhoeae from the Pharynx, Rectum & Urethra of MSM Julius Schachter, PhD Sexually Transmitted Infections (STIs)
Detection of Viral Pathogens in Indian Patients Who Have Suspected Viral Encephalitis Donald E. Ganem, MD Infectious Disease
RNAi as an Intercellular Antiviral Defense Mechanism Raul Andino-Pavlovsky, PhD Infectious Disease, Genetics
RNA Interference and High-Content Image Analysis to Discover New Drug Targets to Treat the Tropical Disease Schistosomiasis Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Novel Mechanisms of Beta-Lactam Resistance in Staph aureus Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance
Translational Studies of Antimalarial Drug Resistance Philip J. Rosenthal, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Framework to Address Drug Resistant Infections and Global Health Joseph L. Derisi, PhD Infectious Disease
A New Field Assay to Diagnose and Monitor Schistosomiasis Conor R. Caffrey, PhD Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
WSA-CS-003: Open Label Study of Isavuconazole in the Treatment of Patients with Aspergillosis and Renal Impairment or of Patients with Invasive Fungal Disease Caused by Rare Molds, Yeasts or Dimorphic Fungi Peter Chin-Hong, MD Infectious Disease, Opportunistic Infection, Pharmacology and Drug Treatment
Study of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Who Have Chronic HCV-1/HIV-1 Co-Infection and Are Treatment-Naïve for Hepatitis C C. Brad Hare, MD Infectious Disease, HIV/AIDS
Using Pan-Pathogen Microarrays and Deep Sequencing to Search for the Cause of Southern Tick-Associated Rash Illness (STARI) Charles Y. Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance
Predicting and Improving Critical Outcomes for Bacterial Keratitis Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Translation Regulation in Giardia lamblia Ching C. Wang, MD Infectious Disease, Genetics
Hepatitis Care Coordination in Methadone Treatment Carmen L. Masson, PhD Infectious Disease, Substance Abuse
Novel Therapeutics for Class B Protozoa Neglected Tropical Diseases (NTDs)
M13-099: Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis (TURQUOISE-II) Norah A. Terrault, MD Infectious Disease, Pharmacology and Drug Treatment
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense Pathogens Charles Y. Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Epidemiologic Effects of ART on HIV-related Anal Cancer and Anal Dysplasia Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
Early Diagnosis of Human Prion Disease Michael D. Geschwind, MD, PhD Infectious Disease, Drug and Diagnostics Development
In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies J. Michael McCune, MD, PhD Infectious Disease, Neglected Tropical Diseases (NTDs), Pediatrics
Age-Dependent Immune Responses to Hepatitis B: a Mouse Model of Human Disease Jody L. Baron, MD, PhD Infectious Disease, Sexually Transmitted Infections (STIs)
K777 for the Treatment of Chagas' Disease, IND-enabling Studies and IND Submission Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
CDC Preparedness and Emergency Response Research Center Travis C. Porco, PhD, MPH Zoonosis, Emerging Disease, and Drug Resistance
HCV Prevention and Care Education Kimberly A. Page, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), Patient and Peer Education
Mycotic Ulcer Treatment Trial (MUTT) Nisha Acharya, MD Infectious Disease, Eye Disease and Blindness
Regulation of the Development of Trypanosoma brucei Ching C. Wang, MD Neglected Tropical Diseases (NTDs)
C. elegans as a Targeted Molecular Surrogate for Filarid Parasites Zoonosis, Emerging Disease, and Drug Resistance
Predicting and Improving Outcomes in Bacterial and Fungal Keratitis Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Identifying Community Factors Impacting STIs among Youth in California Claire Brindis, DrPH Sexually Transmitted Infections (STIs), Adolescent Health
Microbicide Pregnancy Registry--Microbicide Trials Network Juan E. Vargas, MD Sexually Transmitted Infections (STIs), Drug and Diagnostics Development, Women's Health, Family Planning
Research to Programs for Trachoma Elimination Thomas M. Lietman, MD Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
Digital Disease Detection and Molecular Epidemiology of Viral Pathogens in Peru Simon D. Pollett, MBBS Infectious Disease, Epidemiology and Surveillance
Trial of T.cruzi DNA Vaccine in Experimental Model of Disease Challenge Infection Neglected Tropical Diseases (NTDs)
Public Health Research, Epidemiology, and Surveillance for Hemoglobinopathies (PHRESH) Sickle Cell Disease (SCD)/ Thalassemia Case Reporting James Huang, MD Infectious Disease, Genetics, Health Systems Strengthening, Risk Reduction and Prevention
TO#1: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward L. Murphy, MD, MPH Infectious Disease, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
Genetic Diversity as a Determinant of Viral Pathogenesis and Attenuation Raul Andino-Pavlovsky, PhD Infectious Disease, Genetics, Risk Reduction and Prevention
Broad-UCSF Visceral Leishmania Screening Collaboration Neglected Tropical Diseases (NTDs)
VX11-950-115 An Open Label, Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1) C. Brad Hare, MD Sexually Transmitted Infections (STIs), HIV/AIDS
Diagnostic Antibody for Type A Botulism James D. Marks, MD, PhD Infectious Disease, Drug and Diagnostics Development
Detection and Discovery of Viral Pathogens Associated with Dengue-like Symptoms in Nicaragua Joseph L. Derisi, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance
Biotest Analysis for HCMV Infection in Placentas Lenore Pereira, PhD Infectious Disease, Pharmacology and Drug Treatment, Women's Health, Newborn and Infant Health
Anal Cytology/HPV Testing Study Joel Palefsky, MD Infectious Disease, Cancer/Oncology, Systematic Reviews and Guideline Development
Broad Spectrum Antivirals Targeting Envelope Proteolysis and Viral Uncoating Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Comprehensive Diagnostics for Viral Encephalitis/Meningitis Charles Y. Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
2013 NIH Workshop on Protein Homeostasis and Viral Infection Raul Andino-Pavlovsky, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Lead Identification to Clinical Candidate Selection: Drugs for Chagas' Disease Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Student and Postdoctoral Collaborations Travel Award Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Residencies, Fellowships, and Postdoctoral Training
Regulation of Virulence Traits in a Fungal Pathogen of Cancer Patients Sinem Beyhan-Pelvan, PhD Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease
Identification and Validation of Targets of Phenotypic High Throughput Screening Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy with Genotype 1 Chronic Hepatitis C Anne F. Luetkemeyer, MD Sexually Transmitted Infections (STIs)
APTIMA HPV Clinical Study on Anal Specimens from Men Who Have Sex with Men (MSM) Joel Palefsky, MD Sexually Transmitted Infections (STIs)
Acute Hepatitis C Infection in Young Injectors Kimberly A. Page, PhD, MPH Infectious Disease, Adolescent Health, Substance Abuse
Multiplexed Viral and Cytokine Response Assays Using NanoString Technology Charles Y. Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Pathogen Discovery in PREDICT Human and Wildlife samples to Detect and Identify Viruses Present, Both Known and Novel Charles Y. Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Host and Viral Predictors of Prediabetes in at-risk Latinos with Chronic Hepatitis C (HCV) Mandana Khalili, MD Infectious Disease, Diabetes
Screening and Management of Chronic Hepatitis B Virus Infection: A Survey of San Francisco Health Care Providers Mandana Khalili, MD Infectious Disease
Structure and Engineering of Natural Product Cytochrome P450 Larissa Podust, PhD Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Viral Discovery in Idiopathic Pulmonary Fibrosis (IPF) [II] Harold Collard, MD Zoonosis, Emerging Disease, and Drug Resistance, Chronic Respiratory Disease
Clin 0003 Identification and Characterization of a Putative Novel Poxvirus in the DRC Charles Y. Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
NK Cell Biology Lewis L. Lanier, PhD Infectious Disease, Noncommunicable and/or Chronic Disease, Diabetes, Risk Reduction and Prevention
Clin 0004 Characterization of Viral Hemorrhagic Fevers of Unknown Origin Charles Y. Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Systems-Based Analysis of Flaviviral Host Restriction Nevan J. Krogan, PhD, MSc Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Tools for the Endgame: Accelerating the development and introduction of Dx to Support the London Declaration 2020 goals for Neglected Tropical Diseases (NTDs) Thomas M. Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
Deep Sequencing Clinical Analysis Tool for Infectious Disease Steven A. Miller, MD, PhD Infectious Disease, Drug and Diagnostics Development
Genome-Wide Association Study to Examine Genes Associated with An Increased Risk of Febrile Seizure in Children Following Measles-Containing Vaccines Mark Seielstad, PhD Infectious Disease, Pharmacology and Drug Treatment, Pediatrics
GS-US-337-0123 A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who have Advanced Liver Disease or are Post- Norah A. Terrault, MD Infectious Disease
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients Peter G. Stock, MD, PhD Infectious Disease, HIV/AIDS
Host-pathogen Interactions during Vertical Transmission of Listeria monocytogenes Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Women's Health, Labor and Delivery, Newborn and Infant Health
Gene Circuits that Control Morphology in Histoplasma Anita Sil, MD, PhD Infectious Disease, Opportunistic Infection
An Automated High Throughput Phenotypic Screen for Schistosomiasis Drug Discovery Conor R. Caffrey, PhD Infectious Disease, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Preventing Fucose-Dependent Binding of Aspergillus and Pseudomonas to Lung Mucin John V. Fahy, MD Infectious Disease, Chronic Respiratory Disease, Genetics
HPV Cervical Neoplasia in a Long-Term HIV+ Cohort Joel Palefsky, MD Sexually Transmitted Infections (STIs), Cancer/Oncology, Women's Health
HPV & Cervix Neoplasia in a Large, Long Term HIV+ Cohort Teresa M. Darragh, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology
Bartonella henselae: Mechanisms of Chronic Bloodstream Infection Jane Koehler, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Structure-Aided Design of CYP51 Inhibitors for Treatment of Parasitic Infections Larissa Podust, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
International Clinics on Infectious Disease Dynamics and Data (ICI3D Program) Travis C. Porco, PhD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Training International Scholars and Clinicians
CCD Study- RNA Sequencing Charles Y. Chiu, MD, PhD Infectious Disease, Drug and Diagnostics Development
Role of Host Cells in Invasive Listeriosis Anna I. Bakardjiev, MD Infectious Disease
Protocol GS-US-334-0139 An Expanded Access Phase 2 Study of Sofosbuvir and Ribavarin with or without Pegylated Interferon for 24 Weeks in Subjects Who Have Undergone Liver Transplantation and Who Have Aggressive Recurrent Hepatitis C Infection Kathleen P. Tebb, PhD Infectious Disease, Cancer/Oncology
Quasispecies and drug resistance Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance
Lead Identification to Clinical Candidate Selection: Drugs for Chagas' Disease Adam R. Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance
Natural History of HPV Infection to Neoplasia Anna-Barbara Moscicki, MD Infectious Disease
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies Philip J. Rosenthal, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria
Racial/Ethnic Differences in Fibrosis Progression in HIV/HCV Co-Infected Women Monika A. Sarkar, MD, MAS Infectious Disease, HIV/AIDS
Microbial Pathogenesis and Host Defense Joanne N. Engel, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Training International Scholars and Clinicians
Family Services Network - Ryan White HIV/AIDS Program C. Brad Hare, MD Infectious Disease, HIV/AIDS, Systematic Reviews and Guideline Development
Small molecule macrofilaricides targeted against PDE4 Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
A schistosome cysteine protease in Th response polarization Conor R. Caffrey, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) Coinfected Subjects (GS-US-334-0123) Anne F. Luetkemeyer, MD Sexually Transmitted Infections (STIs)
Mechansims of poliovirus replication Raul Andino-Pavlovsky, PhD Infectious Disease, Noncommunicable and/or Chronic Disease, Genetics
TANA II Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
Utility of Contact Investigation of Drug Susceptible and Resistant Tuberculosis in Tanzania Elizabeth Fair, PhD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Epidemiology and Surveillance
High throughput proteomics to dissect Chlamydia-host cell interactions Joanne N. Engel, MD, PhD Infectious Disease, Sexually Transmitted Infections (STIs), Genetics, Risk Reduction and Prevention
Analysis of the rapid policy change toward empirical treatment of fever with artemisinin-based combination therapy in Ebola-burdened areas of Liberia Matt Susko, MS Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Malaria, International Health Policy
Human papillomavirus and the impact of needle-free vaccination on incidence in Thai women: a quantitative study Sneh Patel, MS Infectious Disease, Cancer/Oncology, Pediatrics
Phase II-b Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus Crispatus CTV-05 Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Women's Health
Pathogen characterization and discovery by deep sequencing of two major vectors associated with Lyme disease and other tickborne infections Charles Y. Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Replication, Pathogenesis and Evolution of RNA Viruses, Including Dengue Raul Andino-Pavlovsky, PhD Infectious Disease, Neglected Tropical Diseases (NTDs)
Discovery of benzoxaboroles for the treatment of cryptosporidiosis Philip J. Rosenthal, MD Infectious Disease, Drug and Diagnostics Development
Comprehensive Diagnostics for Viral Encephalitis/Meningitis Charles Y. Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Non-invasive diagnosis of viable adult filarial infections Judy A. Sakanari, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Berkeley's Minority Health/Global Health Training Program Philip J. Rosenthal, MD Neglected Tropical Diseases (NTDs), HIV/AIDS, Malaria, Residencies, Fellowships, and Postdoctoral Training
Antibacterial Resistance Leadership Group (ARIG) Henry Chambers, MD Zoonosis, Emerging Disease, and Drug Resistance, Systematic Reviews and Guideline Development
Linking Virus Population Genetic Structure to Infectivity and Adaptation Raul Andino-Pavlovsky, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB In Vivo Payam Nahid, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
Targeting host autophagy for treating Mtb infections and synergizing with antibiotics in vivo Jeffery S. Cox, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment
Auranofin supplies to test as a macrofilaricide for human onchocerciasis Jaime Sepulveda, MD, DSc, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
GINI: Gardasil Immunogenicity with Needle-free Injection-Safety and Immunogenicity of Gardasil using IM and ID needle-free injection delivery Joel Palefsky, MD Sexually Transmitted Infections (STIs), Cancer/Oncology
Viral Pathogen Discovery in Opportunistic Infections in the Post-Transplant Setting Peter Chin-Hong, MD Infectious Disease, Opportunistic Infection, Surgery and Anesthesia
Philippine-UC Collaboratory for Device Innovation (Education/Training Award) Michael R. Harrison, MD Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Drug and Diagnostics Development, Genetics, Training International Scholars and Clinicians
California Emerging Infections Program Ina U. Park, MD Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance, Health Systems Strengthening, UCSF Professional Education
P-S RPB - Assessing Corneal Ulcer Prevention with a Community-Randomized Trial Thomas M. Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Identifying inhibitors of Parasitic Worm Activity Conor R. Caffrey, PhD Zoonosis, Emerging Disease, and Drug Resistance
A Clinical Trial for Uncomplicated Skin Infections in Areas of Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Henry Chambers, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
NIH-NIAID - MAC isolates for Study at NIH 20150629 Jennifer M. Puck, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
GS_US_342-1139: Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 12 Weeks in Subjects with Chronic Genotype 2 HCV Infecti Anne F. Luetkemeyer, MD Infectious Disease, Pharmacology and Drug Treatment
Thai Red Cross S&S, HN177 Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology
NK Cell Receptors and Their Ligands Lewis L. Lanier, PhD Infectious Disease, HIV/AIDS
Approaches to Discover and Quantify Apoptotic Biomarkers for Cancer Treatment James Wells, PhD Infectious Disease, Cancer/Oncology, Risk Reduction and Prevention
Genetic Diversity as a Determinant of Viral Adaptation and Pathogenesis Raul Andino-Pavlovsky, PhD Infectious Disease, Immunology
Predictors of Cardiomyopathy Progression in a Cohort of Bolivian Patients with Chagas Disease Caryn L. Bern, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Cardiovascular Disease
Pathogenesis of HIV-Related Bacillary Angiomatosis Jane Koehler, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing Charles Y. Chiu, MD, PhD Infectious Disease, Drug and Diagnostics Development
Processing Uganda Swabs for Trachoma Alternative Indicators Study Julius Schachter, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Molecular Dissection of Histoplasma-Induced Host-Cell Death Anita Sil, MD, PhD Infectious Disease
Schistosome Research Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
International Collaborative of prospective studies of HIV and Hepatitis in IDU Stephen Shiboski, PhD Sexually Transmitted Infections (STIs), Cancer/Oncology
Exploring Statins As a Small Molecule Therapy for Treatment of Schistosomiasis Conor R. Caffrey, PhD Neglected Tropical Diseases (NTDs), Noncommunicable and/or Chronic Disease, Risk Reduction and Prevention
Defining Natural History and Optimal Treatment Outcome for Chronic HBV Infection Kathleen P. Tebb, PhD Infectious Disease
Bay Area Hepatitis C Cooperative Research Center J. Michael McCune, MD, PhD Infectious Disease, Sexually Transmitted Infections (STIs)
Whole Blood/Serum Samples from Patients with Hepatitis Charles Y. Chiu, MD, PhD Infectious Disease, Drug and Diagnostics Development
Real-Time Detection of Bloodborne Pathogens by Unbiased Nanopore Sequencing 20150506 Charles Y. Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Accurate, long-read sequencing with droplet-microfluidic barcoding Adam Abate, PhD Infectious Disease, Cancer/Oncology, Genetics
The Impact of Tolerance in the Newborn on Lentiviral Infection J. Michael McCune, MD, PhD Infectious Disease, Pediatrics
Preclinical Development of MucoCept Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Women's Health
RAPID: Ebola virus population structure, genetic diversity and evolution Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment
A Phase 2b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders Norah A. Terrault, MD Infectious Disease, HIV/AIDS, Drug and Diagnostics Development
Designing Selective Inhibitors of Calcium-Dependent Kinases in Parasites Kevan Shokat, PhD Zoonosis, Emerging Disease, and Drug Resistance
Trefoil Factors Regulate Th2 Immunity De'Broski Herbert, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Immunology
A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 weeks in Subjects with Chronic HCV and HIV-1 Coinfection Anne F. Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
A Patient-Centered Intervention to Increase Screening of Hepatitis B and C among Asian Americans Tung T. Nguyen, MD Infectious Disease
Mycotic Ulcer Treatment Trial Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
HPV Testing Contract for UPR NIDCR-funded R21, "Detection of HPV infection in the oral cavity of Hispanics with and without periodontal disease" Joel Palefsky, MD Infectious Disease, Oral Health
Kinetoplastid Drug Development: Strengthening the Preclinical Pipeline Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Serological prevalence of viral hemorrhagic fevers in Equatorial Africa Charles Y. Chiu, MD, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy Anne F. Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Metabiota - Viral Surveillance for the PREDICT Program 20150410 Charles Y. Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Reducing Health Disparities in Unintended Pregnancies Among Hispanic Adolescents Using a Patient-Centered Computer-Based Clinic Intervention Kathleen P. Tebb, PhD Sexually Transmitted Infections (STIs), Family Planning, Adolescent Health
Development of the infant gastrointestinal virome and shedding of oral polio and rotavirus vaccines in Bangladeshi and US infants Charles Y. Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Newborn and Infant Health
Fighting Infections through Research, Science and Technology (FIRST) Phase 1 and 2: Creating a Partnership to Fight Neglected Infectious Disease in Mesoamerica Jaime Sepulveda, MD, DSc, MPH Neglected Tropical Diseases (NTDs), Health Systems Strengthening
Harvesting of S. Mansoni schistosoma eggs Zoonosis, Emerging Disease, and Drug Resistance
Genomic Technology Development and Infectious Diseases Joseph L. Derisi, PhD Infectious Disease
Fighting Infections through Research, Science and Technology (FIRST) Service Contract Jaime Sepulveda, MD, DSc, MPH Neglected Tropical Diseases (NTDs), Health Systems Strengthening
Developing a Macrofilaricidal Drug for Onchocerciasis Using Anacor's Novel Oxaborole Technology Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing Charles Y. Chiu, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Profiling of Collaborator's Small Molecule Anti-filarials Judy A. Sakanari, PhD Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)